semaglutide renal impairment dosing in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial In patients with type 2

From the December 01, 2024 Issue of MM+M - Medical Marketing and Media

We discovered eight phytochemicals (Fig

For patients with type 2 diabetes, dosage adjustments of concomitant oral antidiabetic products may be needed

Managing Patients on Prednisone Initial Consultation and Education: Understanding Prednisone: Its important that patients understand why prednisone has been prescribed, its significant potential side effects, and the importance of adherence to the prescribed dose and duration

But playing offense in the GLP-1 space is going to be developing unique ingredients that will be specific to GLP-1

During the first 3 months, most people are still in the dose escalation phase